Lauren P. Silvernail

Lauren P. Silvernail is a declared insider at 4 companies (chief executive); the most frequent names are Revance Therapeutics, Inc., Evolus, Inc. and Dynavax Technologies Corp. Over a trading history stretching from 31 December 2015 to 10 February 2026, the count stands at 44 filings.

The open-market record consists of 15 sales worth €3.2M, with no purchase. Other entries cover 16 share grants and 6 option exercises.

Most recently, on 10 February 2026, the filings show a transaction in Dynavax Technologies Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.